Getein Biotech, Inc (603387.SS)
CNY 8.59
(-0.12%)
CNY 8.59
(-0.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 333.22 Million | 482.95 Million | 432.36 Million | 185.46 Million | 225.73 Million | 187.09 Million |
| Net Income | 284.08 Million | 503.94 Million | 412.01 Million | 330.31 Million | 349.94 Million | 250.64 Million |
| Depreciation & Amortization | 93.08 Million | 70.35 Million | 49.4 Million | 35.92 Million | 27.93 Million | 24.75 Million |
| Deferred income taxes | -5.91 Million | -10.32 Million | -1.6 Million | 5.19 Million | -1.82 Million | -1.34 Million |
| Stock-based compensation | - | - | - | 1.63 Million | 4.07 Million | 10.98 Million |
| Change in working capital | -72.08 Million | -120.22 Million | -38.26 Million | -175.06 Million | -147.24 Million | -73.85 Million |
| Other non-cash items | 14.39 Million | 28.88 Million | 9.21 Million | -12.53 Million | -7.16 Million | -14.44 Million |
| Investing Cash Flow | -356.82 Million | -760.44 Million | -254.63 Million | -238.71 Million | 261.75 Million | -345.51 Million |
| Investments in PPE | -258.12 Million | -217.44 Million | -179.59 Million | -113.53 Million | -124.81 Million | -110.74 Million |
| Acquisitions | 3.22 Million | 15.87 Million | 2.87 Million | -54.05 Million | 133.5 Million | 4.27 Million |
| Investment purchases | -433.45 Million | -1.02 Billion | -132.41 Million | -120.79 Million | -84.85 Million | -264.47 Million |
| Sales/Maturities of investments | 322.87 Million | 478.98 Million | 56.8 Million | 45.5 Million | 462.74 Million | 35.12 Million |
| Other Investing Activities | -98.69 Million | -11.3 Million | -2.29 Million | 4.16 Million | -124.81 Million | -9.69 Million |
| Financing Cash Flow | -145.87 Million | -45.88 Million | -28.92 Million | 200 Million | 25.93 Million | -1.5 Million |
| Debt repayment | -73.44 Million | -699.9 Million | -376.45 Million | -364.18 Million | -40 Million | - |
| Dividends payments | -202.86 Million | -123.16 Million | -93.16 Million | -104.15 Million | -76.26 Million | -59.8 Million |
| Common Stock Repurchased | - | - | -50.38 Million | -541.83 Thousand | -535.21 Thousand | -654.34 Thousand |
| Common Stock Issuance | - | - | 50.38 Million | 541.83 Thousand | 535.21 Thousand | 58.94 Million |
| Other Financing Activities | 1.55 Million | 794.75 Million | 451.09 Million | 680.01 Million | 143.78 Million | 58.29 Million |
| Accounts receivables | -2.45 Million | -111.24 Million | -49.52 Million | -200.28 Million | -163.86 Million | -62.48 Million |
| Accounts payables | -81.05 Million | 53.59 Million | 56.13 Million | 60.28 Million | 54.24 Million | 53.35 Million |
| Inventory | 17.34 Million | -52.24 Million | -43.26 Million | -40.26 Million | -35.79 Million | -63.37 Million |
| Other working capital | -86.97 Million | -10.32 Million | -1.6 Million | 5.19 Million | -1.82 Million | -10.48 Million |
| Cash at beginning of period | 640.98 Million | 945.15 Million | 797.36 Million | 656.65 Million | 142.41 Million | 301.02 Million |
| Cash at end of period | 483.17 Million | 640.98 Million | 945.15 Million | 797.36 Million | 656.65 Million | 142.41 Million |
| Capital Expenditure | -258.12 Million | -217.44 Million | -179.59 Million | -113.53 Million | -124.81 Million | -110.74 Million |
| Effect of forex changes on cash | 11.67 Million | 19.2 Million | -1.02 Million | -6.04 Million | 812.43 Thousand | 1.31 Million |
| Net cash flow / Change in cash | -157.81 Million | -304.16 Million | 147.78 Million | 140.71 Million | 514.23 Million | -158.61 Million |
| Free Cash Flow | 75.09 Million | 265.51 Million | 252.76 Million | 71.93 Million | 100.91 Million | 76.35 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 55.47 Million | 60.79 Million | 86.01 Million | 284.08 Million | 50.7 Million | 60.34 Million |
| Depreciation & Amortization | - | 26.84 Million | 26.84 Million | 93.08 Million | 93.08 Million | -45.79 Million |
| Deferred income taxes | - | - | - | -5.91 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -72.08 Million | 14.89 Million | 18.42 Million |
| Other non-cash items | 47.39 Million | 63.56 Million | -13.39 Million | 14.39 Million | 28.03 Million | -5.17 Million |
| Investing Cash Flow | -41.99 Million | 19.06 Million | -100.41 Million | -356.82 Million | -7.72 Million | -192.67 Million |
| Investments in PPE | -10.82 Million | -5.62 Million | -36.7 Million | -258.12 Million | -98.26 Million | -42.75 Million |
| Acquisitions | 145.01 Thousand | 159.53 Thousand | 210.56 Thousand | 3.22 Million | 2.58 Million | 476.45 Thousand |
| Investment purchases | -121.41 Million | -131.85 Million | -144.64 Million | -433.45 Million | 358.26 Million | -242.72 Million |
| Sales/Maturities of investments | 90.09 Million | 156.37 Million | 80.72 Million | 322.87 Million | -277.71 Million | 92.33 Million |
| Other Investing Activities | - | 159.53 Thousand | -63.71 Million | -98.69 Million | 90.53 Million | -1401.73 |
| Financing Cash Flow | 38.87 Million | -59.83 Million | -32.99 Million | -145.87 Million | -106.93 Million | 35.77 Million |
| Debt repayment | -102.96 Million | -3.29 Million | -25.09 Million | -73.44 Million | -104.14 Million | -152.78 Million |
| Dividends payments | - | -49.27 Million | -7.66 Million | -202.86 Million | -202.86 Million | -54.18 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -64.09 Million | -2.37 Million | -240 Thousand | 1.55 Million | 2.29 Million | 242.74 Million |
| Accounts receivables | - | - | - | -2.45 Million | -2.45 Million | 5.91 Million |
| Accounts payables | - | - | - | -81.05 Million | - | - |
| Inventory | - | - | - | 17.34 Million | 17.34 Million | 12.5 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 474.26 Million | 417.28 Million | 483.17 Million | 640.98 Million | 407.47 Million | 538.07 Million |
| Cash at end of period | 568.87 Million | 473.76 Million | 417.28 Million | 483.17 Million | 483.17 Million | 407.47 Million |
| Capital Expenditure | -10.82 Million | -5.62 Million | -36.7 Million | -258.12 Million | -98.26 Million | -42.75 Million |
| Effect of forex changes on cash | - | 1.3 Million | 410.24 Thousand | 11.67 Million | 2.78 Million | -1.49 Million |
| Net cash flow / Change in cash | 94.6 Million | 56.47 Million | -65.88 Million | -157.81 Million | 75.7 Million | -130.6 Million |
| Free Cash Flow | 92.04 Million | 91.89 Million | 35.91 Million | 75.09 Million | 88.44 Million | -14.96 Million |
SYRMA
FRS
DIA
BBAR
DIS
TSQ